Artal Group’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,057,949
| Closed | -$18.5M | – | 18 |
|
|
2024
Q2 | $18.5M | Buy |
+1,057,949
| New | +$18.5M | 0.47% | 26 |
|
|
2023
Q3 | – | Sell |
-250,000
| Closed | -$2.69M | – | 104 |
|
|
2023
Q2 | $2.69M | Hold |
250,000
| – | – | 0.08% | 74 |
|
|
2023
Q1 | $2.56M | Hold |
250,000
| – | – | 0.15% | 76 |
|
|
2022
Q4 | $2.64M | Hold |
250,000
| – | – | 0.15% | 75 |
|
|
2022
Q3 | $3.21M | Hold |
250,000
| – | – | 0.14% | 73 |
|
|
2022
Q2 | $3.21M | Hold |
250,000
| – | – | 0.17% | 77 |
|
|
2022
Q1 | $2.62M | Hold |
250,000
| – | – | 0.11% | 104 |
|
|
2021
Q4 | $3.86M | Buy |
250,000
+150,000
| +150% | +$2.31M | 0.1% | 108 |
|
|
2021
Q3 | $2.26M | Hold |
100,000
| – | – | 0.05% | 127 |
|
|
2021
Q2 | $2.58M | Hold |
100,000
| – | – | 0.05% | 127 |
|
|
2021
Q1 | $4.17M | Buy |
+100,000
| New | +$4.17M | 0.07% | 112 |
|